What are the genetic and acquired risk factors for thrombosis? How is it treated, and what follow-up is required? Two experts offer some answers&151;and call for additional research.
Marinus discontinuing oral ganaxolone trial development to treat seizures in children
The TrustTSC trial did not achieve its primary endpoint of percent reduction in 28-day frequency of TSC-associated seizures.
Food Insecurity and the Dangers of Infant Formula Dilution
Pneumococcal conjugate vaccine: A glimpse into current recommendations
Infants, young children, and older adults are at the highest risk for pneumococcal infection, and viral illnesses, such as influenza, may predispose sensitive groups to pneumococcal infection.
Demystifying Infant Formula
Galinpepimut-S to treat pediatric acute myeloid leukemia receives Rare Disease Designation
Interim analysis of the phase 3 REGAL Trial is anticipated in this quarter of 2024.
Maternal influenza linked to offspring seizure risk
In a recent study, infants of mothers with an influenza infection during pregnancy were significantly more likely to experience febrile seizures, but not epilepsy.